Ilico Genetics
Santiago, CL · 1 known investors
Ilico Genetics develops a blood-based molecular test for the early detection of gastric cancer using methylated DNA markers, designed to identify disease years before traditional methods. The company serves gastroenterologists and patients in the oncology diagnostics space, with a platform technology applicable to precision medicine and disease prevention.
Founders & leadership
Investors · 1
In the news
- LSGI INVESTS >$238K IN ILICO GENETICS — LSG Investmentslsgpa.com · 2023